Garrison Michael David

EVP & Pres Med.Essntl&BioPharmBECTON DICKINSON & CO (BDX) · full profile →Form 4 · filed Jan 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$334K
Net Open-Market Flow
-$334K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 15, 2026Sell(S)1K$206.54$209K12K
Jan 15, 2026Sell(S)600$209.00$125K13K
Jan 15, 2026Option exercise(M)3K$167.91$513K16K
Jan 15, 2026Disposed to issuer(D)2K$209.00$513K14K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 15, 2026Option exercise(M)3K$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001944816-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: